HALOZYME THERAPEUTICS: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to HALOZYME THERAPEUTICS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 21 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | CORI BUSH FOR CONGRESSC00638767 | 2024-02-04 | $500 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1788867 · amendedFEC filing ↗ |
| 22 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2023-11-13 | $500 | Not reported | EARMARKED FOR RASHIDA TLAIB FOR CONGRESS (C00668608)Filing 1752852FEC filing ↗ |
| 23 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2023-11-22 | $500 | Not reported | EARMARKED FOR JUSTICE DEMOCRATS (C00630665)Filing 1752852FEC filing ↗ |
| 24 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-02-01 | $500 | Primary (P) | EARMARKED FOR COMMITTEE TO ELECT NASSER BEYDOUN (C00837112)Filing 1765652FEC filing ↗ |
| 25 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | BARBARA LEE FOR US SENATEC00833608 | 2024-01-27 | $500 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1759215FEC filing ↗ |
| 26 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | RASHIDA TLAIB FOR CONGRESSC00668608 | 2023-11-13 | $500 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753160FEC filing ↗ |
| 27 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-02-04 | $500 | Primary (P) | EARMARKED FOR CORI BUSH FOR CONGRESS (C00638767)Filing 1765652FEC filing ↗ |
| 28 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-03-08 | $500 | Primary (P) | EARMARKED FOR CORI BUSH FOR CONGRESS (C00638767)Filing 1779040FEC filing ↗ |
| 29 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-02-04 | $500 | Primary (P) | EARMARKED FOR BOWMAN FOR CONGRESS (C00709196)Filing 1765652FEC filing ↗ |
| 30 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-10-20 | $500 | Primary (P) | EARMARKED FOR LATEEFAH SIMON FOR CONGRESS (C00834291)Filing 1857001FEC filing ↗ |
| 31 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | CORI BUSH FOR CONGRESSC00638767 | 2024-03-08 | $500 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1788867 · amendedFEC filing ↗ |
| 32 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2023-05-16 | $1,000 | Primary (P) | EARMARKED FOR BARBARA LEE FOR U.S. SENATE (C00833608)Filing 1720554FEC filing ↗ |
| 33 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | BARBARA LEE FOR US SENATEC00833608 | 2023-05-16 | $1,000 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1774880 · amendedFEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.